2019
Past Studies — Bascom Palmer
Retinal Imaging in strabismus and pediatric disease
Kostic M. (Data analysis, screening, recruitment, participant), “Retinal Imaging in strabismus and pediatric disease”, (Cavuoto) 3/7/2018-3/6/2019.
Academic record
Research & Trials
Searchable records from the living academic CV.
2019
Past Studies — Bascom Palmer
Diplopia
Kostic M. (Co-investigator), “Diplopia”, (Capo) 8/23/2018-07/01/2019
2019
Past Studies — Bascom Palmer
Screening and treatment Experience for Retinopathy of Prematurity (ROP) at Bascom Palmer Eye Institute (BPEI)
Kostic M. (Data analysis, screening, recruitment, participant). “Screening and treatment Experience for Retinopathy of Prematurity (ROP) at Bascom Palmer Eye Institute (BPEI)”, (Berrocal) 7/2/2018-7/1/2019.
Active IRB Studies
The Effect of Emergency Room Treatment Timelines on Visual outcomes of Idiopathic Intracranial Hypertension, 21-1037 (Active)
Kostic M. (PI): The Effect of Emergency Room Treatment Timelines on Visual outcomes of Idiopathic Intracranial Hypertension, 21-1037 (Active).
Active IRB Studies
Kostic M. (Co-investigator): Collaborative Eye Exams for the Preterm Infant, 21-1788
Kostic M. (Co-investigator): Collaborative Eye Exams for the Preterm Infant, 21-1788, PI:McCarty Dana (Active).
Active IRB Studies
Kostic M. (Co-investigator): Optic Nerve Sheath Diameter and Eye Movement, 21-1837
Kostic M. (Co-investigator): Optic Nerve Sheath Diameter and Eye Movement, 21-1837, PI: David Fleischman (Active).
2024
Active IRB Studies
Kostic M. (Co-investigator): ROP3: A Randomized Trial of Low-Dose Bevacizumab versus Laser for Type 1 Retinopathy of Prematurity, 21-1963
Kostic M. (Co-investigator): ROP3: A Randomized Trial of Low-Dose Bevacizumab versus Laser for Type 1 Retinopathy of Prematurity, 21-1963, PI: Michelle Go; (2020-2024).
2024
Active IRB Studies
Kostic M. (Co-investigator): ROP4: Bevacizumab Treatment for Posterior Type 1 Retinopathy of Prematurity, 21-1965
Kostic M. (Co-investigator): ROP4: Bevacizumab Treatment for Posterior Type 1 Retinopathy of Prematurity, 21-1965, PI: Michelle Go; (2020-2024).
Active IRB Studies
Kostic M. (Co-investigator): An iPad-based Visual Field Test Evaluating Neuro-ophthalmic Disorders
Kostic M. (Co-investigator): An iPad-based Visual Field Test Evaluating Neuro-ophthalmic Disorders, PI: Donald Budenz. (Active).
Active IRB Studies
Kostic M. (Co-investigator): A Phase 2b Trial of the MEK 1/2 Inhibitor (MEKi) PD-0325901 in Adult and Pediatric Patients with Neurofibromatosis Type 1 (NF1) – Associated Inoperabl…
Kostic M. (Co-investigator): A Phase 2b Trial of the MEK 1/2 Inhibitor (MEKi) PD-0325901 in Adult and Pediatric Patients with Neurofibromatosis Type 1 (NF1) - Associated Inoperable Plexiform Neurofibromas (PNs) that are Causing Significant Morbidity, 19-1051 PI: Timothy Gershon to Sponsor: SpringWorks…
2020
Active IRB Studies
Genotype Correlation of Inherited Eye Disease, (Lam) 3/25/2020 – current
Kostic M. (Data analysis, screening, recruitment, participant), Genotype Correlation of Inherited Eye Disease, (Lam) 3/25/2020 – current.
2018
Funded Research & Clinical Trials
Clinical applications of advanced ophthalmic imaging
Kostic M. (Data analysis, screening, recruitment, participant), “Clinical applications of advanced ophthalmic imaging”, Sponsored by National Multiple Sclerosis Society RG-1506-04890; 04/01/2016—2018. $540 834.
2024
Funded Research & Clinical Trials
Ageing and role of the eye in systemic and neurodegenerative diseases
Kostic M. (Data analysis, screening, recruitment, participant), “Ageing and role of the eye in systemic and neurodegenerative diseases”, (Cabrera DeBuc) Sponsored by The Finker-Frenkel Legacy Foundation 01/01/2015-12/31/2019 $140,000, Alzheimer’s Association 09/01/2017-08/31/2019 $120 000 and NIH Institute of Aging 12/01/2017-2024 $241000.
2023
Funded Research & Clinical Trials
Neuro-Vascular Changes associated with the Water Drinking Stress Test
Kostic M. (Data analysis, screening, recruitment, participant), “Neuro-Vascular Changes associated with the Water Drinking Stress Test”, No founded (Porciatti), 02/19/2019 – 2023
2017
Funded Research & Clinical Trials
Retinal Ganglion Cell Plasticity in Glaucoma
Kostic M. (Data analysis, screening, recruitment, participant), “Retinal Ganglion Cell Plasticity in Glaucoma”, Sponsored by NIH/NEI 2R01EY019077 (Porciatti) 08/01/2012 – 07/31/2017, NIH/NEI No-cost extension.
2018
Funded Research & Clinical Trials
Reversible Dysfunction of Retinal Ganglion Cells in Glaucoma
Kostic M. (Data analysis, screening, recruitment, participant), “Reversible Dysfunction of Retinal Ganglion Cells in Glaucoma”, Sponsored by NIH/NEI 2R01EY014957 (Porciatti) 05/01/2014 -04/30/2018, $225,000 DC.
2026
Funded Research & Clinical Trials
TIMELY-PLEX — Early vs. Rescue Plasma Exchange
Treatment of Inflammatory Myelitis and Optic Neuritis with Early vs. Rescue Plasma Exchange (TIMELY-PLEX) Mayo IRB #: 25-000657 | 07/2025–07/2026 Sponsor: Mayo Clinic Role: Co-Investigator – Maja Kostic, MD, MMSc, PhD Open-label, rater-blinded, pragmatic randomized controlled trial evaluating early versus rescue therapeutic…
Funded Research & Clinical Trials
spiriTED — TOUR006 in Thyroid Eye Disease
A Multicenter Phase 2b Randomized, Double-Masked, Placebo-Controlled, Dose-Ranging Study of TOUR006 in Thyroid Eye Disease (spiriTED) ClinicalTrials.gov ID: NCT06088979 Sponsor: Tourmaline Bio, Inc. Role: Sub-Investigator – Maja Kostic, MD, MMSc, PhD PI: Sara Wester, MD Phase 2b trial assessing efficacy and safety…
Funded Research & Clinical Trials
OCU400 Gene Therapy for Retinitis Pigmentosa
A Phase 3 Study of OCU400 Gene Therapy for the Treatment of Retinitis Pigmentosa ClinicalTrials.gov ID: NCT06388200 Sponsor: Ocugen Role: Sub-Investigator – Maja Kostic, MD, MMSc, PhD PI: Byron L. Lam, MD This is a Phase 3 study to Assess the Efficacy,…
2024
Funded Research & Grants
06/06/2024 – present – Private Donor Grant (Mr. and Mrs. Maounis) to Maja Kostic (PI): $50.000
06/06/2024 – present – Private Donor Grant (Mr. and Mrs. Maounis) to Maja Kostic (PI): $50.000
2024
Funded Research & Grants
9/19/2024 – present – Private Donor Grant (Mr. and Mrs. Maounis) to Maja Kostic (PI): $50.000
9/19/2024 – present - Private Donor Grant (Mr. and Mrs. Maounis) to Maja Kostic (PI): $50.000
2024
Funded Research & Grants
10/12/2024 – present – Private Donor Grant (Mr. and Mrs. Baxter) to Maja Kostic (PI): $12.5000
10/12/2024 – present - Private Donor Grant (Mr. and Mrs. Baxter) to Maja Kostic (PI): $12.5000
2025
Funded Research & Grants
3/10/2025 – present – Women Leaders in Eye Health, (WLEH) Professional Development Grant to Maja Kostic, Orbis International – $ 3000
3/10/2025 – present - Women Leaders in Eye Health, (WLEH) Professional Development Grant to Maja Kostic, Orbis International - $ 3000